4Cummings SR, Kelsey JL Nevitt MC, et al. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev, 1985, 7: 178- 208. 被引量：1
5Swift CG. Care of older people: falls in late life and their consequences implementing effective services. BMJ, 2001, 322: 855- 857. 被引量：1
6Hoesel LM, Pausch M, Schnettler R, et al. The impact of osteoporosis on the classification of hip and wrist fractures. Med Sci Monit, 2008, 14: 1-8. 被引量：1
7Tuck SP, Datta HK. Osteoporosis in the aging male: treatment options. Clin Interv Aging, 2007, 2: 521-536. 被引量：1
8Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol, and calcitonin. N Engl J Med, 1993, 328: 1747-1752. 被引量：1
9Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ, 2002, 167 (10 Suppl): 1-34. 被引量：1
10Chesnut CH 3rd, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon caleitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotie fraet ures study. PROOF Study Group. Am J Med, 2000, 109: 267-276. 被引量：1
2Ampecht G. In vitro determination of the release of alen- dronic acid from alendronate tablets of different brands during de-glutition[J]. J Pharm Sci, 2009,98 (10) : 3575-3581. 被引量：1
3Management of osteoporosis in postmenopausal women: 2010 position statement of the North American Menopause Society[J]. Menopause, 2010,17 : 25-54. 被引量：1
